Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

17. Oktober 2016 01:00 ET | Quelle: Addex Therapeutics

Addex Therapeutics to Conduct Phase IIa Proof of Concept Study of Dipraglurant in Focal Cervical Dystonia

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Company Expects to Initiate Study in...
11. Oktober 2016 01:00 ET | Quelle: Addex Therapeutics

Addex Initiates New Study in Collaboration with US National Institute of Drug Abuse with ADX88178 in Non-Human Primate Model of Cocaine Addiction

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland, 11 October 2016...
30. September 2016 01:00 ET | Quelle: Addex Therapeutics

Addex Therapeutics Reports First Half 2016 Operating Highlights and Financial Results

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland, 30 September...
20. September 2016 01:00 ET | Quelle: Addex Therapeutics

Addex Collaborators Published New Data Supporting the Role of Negative Allosteric Modulators of Follicle Stimulating Hormone and Luteinizing Hormone Receptors in Reproductive Health

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland, 20 September 2016...
27. Juli 2016 01:00 ET | Quelle: Addex Therapeutics

Addex ADX71441 Demonstrates Positive Results in Highly Translational Preclinical Model of Spasticity.

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland, 27 July 2016 -...
20. Juli 2016 01:00 ET | Quelle: Addex Therapeutics

LifeSci Capital Issues Equity Research Report on Addex Therapeutics

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland, 20 July 2016 -...
24. Juni 2016 01:00 ET | Quelle: Addex Therapeutics

Addex Shareholders Approved all Board Proposals at 2016 Annual General Meeting

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland, 24 June 2016 -...
13. Juni 2016 01:00 ET | Quelle: Addex Therapeutics

Addex mGluR4 and mGluR7 Programs Demonstrate Potential in Preclinical Models of Neurodegenerative and Psychiatric Diseases

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland, 13 June 2016...
09. Juni 2016 01:00 ET | Quelle: Addex Therapeutics

Addex ADX71441 Demonstrates Positive Results in Non-Human Primate Model of Cocaine Addiction

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland, 9 June 2016 -...
08. Juni 2016 01:00 ET | Quelle: Addex Therapeutics

Van Leeuwenhoeck Issues Research Note on Addex Therapeutics

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland, 8 June 2016 -...

Vorherige Seite